A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors

Clinical trial NCT05329103 · RECRUITING

Trial details

NCT number: NCT05329103
Sponsor: Peel Therapeutics Inc
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2022-07-11
Primary completion: 2026-10-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.